UBAP2L anticorps (AA 400-450)
-
- Antigène Voir toutes UBAP2L Anticorps
- UBAP2L (Ubiquitin Associated Protein 2-Like (UBAP2L))
-
Épitope
- AA 400-450
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp UBAP2L est non-conjugé
-
Application
- Western Blotting (WB), Immunoprecipitation (IP)
- Fonction
- Rabbit anti-UBAP2L/NICE4 Antibody, Affinity Purified
- Purification
- Affinity Purified
- Immunogène
- between AA 400 and 450
- Isotype
- IgG
- Top Product
- Discover our top product UBAP2L Anticorps primaire
-
-
- Indications d'application
-
IP: 2 - 10 μg/mg lysate
WB: 1:10,000 - 1:25,000
- Restrictions
- For Research Use only
-
- Concentration
- 1000 μg/mL
- Buffer
- Tris-citrate/phosphate buffer, pH 7 to 8 containing 0.09 % Sodium Azide
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- 4 °C
- Date de péremption
- 12 months
-
- Antigène
- UBAP2L (Ubiquitin Associated Protein 2-Like (UBAP2L))
- Autre désignation
- UBAP2L/NICE4 (UBAP2L Produits)
- Synonymes
- anticorps si:dkey-204a24.7, anticorps NICE-4, anticorps 3110083O19Rik, anticorps 4932431F02Rik, anticorps A430103N23Rik, anticorps C77168, anticorps Nice-4, anticorps mKIAA0144, anticorps ubiquitin associated protein 2 like, anticorps ubiquitin associated protein 2-like, anticorps ubiquitin-associated protein 2-like, anticorps UBAP2L, anticorps ubap2l, anticorps Ubap2l
- Sujet
- Background: Ubiquitin associated protein 2-like (UBAP2L) has been identified as the predicted gene product of a coding sequence deduced by analysis of cDNAs from a human myeloid cell line. UBAP2L was also identified as a cDNA belonging to the epidermal differentiation complex (EDC) which comprises a large number of genes important to human epidermis maturation. A function of UBAP2L has not been assigned.
- ID gène
- 9898
- UniProt
- Q14157
- Pathways
- SARS-CoV-2 Protein Interactome, Phosphorylation & l'infection par le SRAS-CoV-2
-